Related Experiment Videos
A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report
F Pietrogrande1, A Caenazzo, F Dazzi
1Second Chair of Medicine, Institute of Medical Semeiotics, University of Padua, Italy.
Angiology
|July 1, 1995
Abstract:
Generalized vasoconstriction in chronic ergot poisoning is attributed both to the ergotamine activity on alpha-adrenergic receptors and to its direct action on vascular smooth muscle cells. The authors propose that endothelial wall, chronically damaged by ergot alkaloids, releases platelet-derived growth factor (PDGF), which contributes to vasoconstriction and promotes further arterial obstruction. Their hypothesis is supported by the increased PDGF activity found in plasma of a patient suffering from chronic ergotism.